Tarsus Pharmaceuticals Announces Oversubscribed $125.0 Million Private Placement Equity Financing

Summary

Tarsus Pharmaceuticals announced an oversubscribed $125.0 million private placement equity financing with qualified institutional buyers and accredited investors. The financing is expected to generate approximately $125.0 million in gross proceeds before placement agent fees.